Boston lawsuit claims DES-breast cancer link
Fifty-three women from around the country are suing drug companies, including Eli Lilly and Co., who made and promoted DES for millions of pregnant women from about 1938 to the early 1970s.
Health Care
Articles
Healthx receives $22M capital infusion
Frontier Capital in Charlotte, N.C., provided the funding that will support the continued expansion of Healthx, a local provider of online health care portals.
Lilly challenging Biogen patent in London lawsuit
Eli Lilly and Co. has sued Biogen Idec Inc. in a London court to revoke a European patent on a potential treatment for immune-system diseases.
WellPoint, other insurers profit from health law they oppose
Insurance companies spent millions of dollars trying to defeat the U.S. health-care overhaul. But profit margins at the companies have widened to levels not seen since before the recession, a Bloomberg Government study shows.
Lilly’s 2012 earnings forecast misses analyst estimates
Indianapolis-based Eli Lilly and Co. provided a 2012 earnings forecast Thursday morning that missed analyst estimates by a wide margin, sending shares down.
Walgreen expects to lose most Express Scripts biz
Drugstore operator Walgreen Co. said Thursday it expects to lose almost 90 percent of prescriptions handled by pharmacy benefits manager Express Scripts Inc. after it leaves Express Scripts' networks on Jan. 1.
Lilly losing dominance in diabetes treatment
Eli Lilly and Co., after more than a decade of setbacks, is counting on diabetes to help it survive a string of patent losses on other products that have begun to sap the drugmaker’s sales.
Endocyte stays course despite being battered by investors
After spending most of 2011 as a Wall Street darling, the year ended ugly for Endocyte Inc. But CEO Ron Ellis thinks the West Lafayette-based drug developer is in better position than ever.
Q&A
Dr. Bryan Schneider, a professor at the Indiana University School of Medicine, led a team of researchers in identifying genetic variations that dispose some breast cancer patients to neuropathy when they are receiving chemotherapy with the drug Taxol. Schneider’s research was named one of the biggest advances in cancer research this year by the American Society of Clinical Oncology. The society’s foundation also gave Schneider a three-year, $450,000 grant to further the research.
Arcadia agrees to sell DailyMed to Walgreen
It looks like Arcadia Resources Inc.’s DailyMed pharmacy business will live on—but under the wing of Walgreen Co. instead of on its own.
Drugmaker eyes ex-Pfizer plant in western Indiana
Officials say an as-yet-unnamed drug company is looking to take over much of the former Pfizer Inc. complex near Terre Haute that had about 800 workers before it was shut down.
Franciscan group picked for model accountable care program
The Indianapolis-based partnership is among 32 in the U.S. chosen for a model program designed to provide more coordinated care for people served by Medicare.
Hoosiers like parts of health reform law
As it is in the rest of the country, the 2010 health reform in Indiana continues to be unpopular, unlikely to be repealed and uncertain to put a dent in health spending, according to a poll of Hoosiers released last week by Ball State University.
Franciscan among Medicare’s first accountable care groups
Franciscan Alliance’s Indianapolis-area hospitals, along with more than 700 physicians, have been named one of the nation’s first 32 accountable care organizations.
Independent doctors fear loss of referrals
Independent health care facilities, like Body One Physical Therapy, are seeing referrals from physicians beginning to slacken as more and more doctors become employees of hospitals. The hospitals request that doctors send patients to their in-house physical therapy practices.
Planned Parenthood of Indiana brings on new lobbyists
The new hires could be important following last year’s legislative session, in which state lawmakers passed a law to cut off Medicaid funding to groups that offer abortions.
Express Scripts, WellPoint in contract fight
Pharmacy benefits manager Express Scripts Inc. said Tuesday it is in the middle of a contract dispute with WellPoint Inc., one of the biggest health insurers in the United States.
Endocyte shares plunge on clinical trial results
Shares of Endocyte Inc. plummeted more than 60 percent Tuesday morning after clinical trial results showed the company’s experimental ovarian cancer drug led to shorter survival times than treatment with a standard cancer drug.
Ball State: Diabetes rising at alarming rate
In 1993, only 3.8 percent of Hoosier adults had full-blown diabetes, compared with 9.8 percent today.
Medical Mutual eyes Indiana for growth
Health insurer expects enrollment in its health plan to grow 30 percent next year, to nearly 21,000. And then it expects growth of another 40 percent.